Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 9805960

[Phytotherapy].

G Van Snick
View original source ↗Export metadata ↓

Abstract

Herbal medicine is an integral part of general medicine, and therefore uses academic diagnosis. The only difference lies in the use of herbal medication. The use of herbal drugs offers the practionner, as much as the patient, a wider and more specific range of medication. These herbal drugs have been the subject of lengthy researches at universities pharmacology departments. Extensive research has been conducted, ranging from the harmlessness of common herbal drugs to the possibility of new molecule growth cleansing of the active principle of plants with potentially high toxic risk. Our ancester's herbal medicine gives way today to modern medicine, i.e. a wealth of remedies and a high storage for tomorrow's medications.

Explore related subjects

Drug Evaluation, PreclinicalEvidence-Based MedicineHumansPhytotherapyResearchEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G Van Snick. 1998. [Phytotherapy].. https://pubmed.ncbi.nlm.nih.gov/9805960/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Affinity NMR.

Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screening, can be detected and could serve as synthetic precursors for higher affinity ligands. The biggest challenge to NMR methodology lies in its sensitivity. Compared with other techniques, such as MS (25), NMR methods for screening mixtures are limited by their relative insensitivity. Because of issues such as solubility, stability, and mass limitation, it is not in general judicious to simply increase the concentration of the mixture. Improvements in hardware and software are necessary to extend the applicability of the affinity NMR method to the screening of larger and more complex mixtures. A boost in sensitivity and screening capacity of NMR technique is possible by the implementation of microcoil (26) and flow probe techniques. An upsurge in the capabilities of mixture analysis could be achieved with a combination of independent and complementary techniques (e.g., HPLC, MS) (27). As a unique, nondestructive, and versatile tool, NMR will continue on its fast track of development in the support of drug discovery.

Drug Evaluation, Preclinical↗
PubMed1999

Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists.

A series of pyrroloquinazolines has been discovered that represent novel small molecule inhibitors of the intramolecular ligand of the thrombin receptor. Analogs were prepared to study the structure-activity relationships of substitution at the N 1, N3, and N7 positions of the heterocycle. Compounds 4e and 4f have been identified with IC50's of 56 and 52 nM, respectively.

Drug Evaluation, Preclinical↗